Study title:
Graf, Hallén. Effect on the Nasal Mucosa of Long-Term Treatment With Oxymetazoline, Benzalkonium Chloride, and Placebo Nasal Sprays. Laryngoscope 1996; 106:605-609Graf, Hallén. Effect on the Nasal Mucosa of Long-Term Treatment With Oxymetazoline, Benzalkonium Chloride, and Placebo Nasal Sprays. Laryngoscope 1996; 106:605-609
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Respiratory Tract Diseases
|
Brands: Please see report, Please see report, Please see report |
MAH holders: Please see report, Please see report |
Assessment: |
Active substance: OXYMETAZOLINE |
ATC code: R01A A05
|
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
-
|
-
|